2017 Regular Session
|At the request of:|
|Bill Title:||Relating to the program used to monitor the dispensing of prescription drugs; declaring an emergency.|
Requires pharmacy to report de-identified information to prescription monitoring program upon dispensing prescribed naloxone.
Requires pharmacy to report certain other identifying information to prescription monitoring program upon dispensing prescribed controlled substance classified in schedules II through IV. Requires information to be disclosed from prescription monitoring program to medical director or pharmacy director. Requires information to be disclosed from prescription monitoring program for certain other purposes. Requires licensing information of licensees who are authorized to prescribe or dispense controlled substances to be provided to Oregon Health Authority for purpose of qualifying licensees to report information to, or receive information from, prescription monitoring program. Becomes operative January 1, 2018. Declares emergency, effective on passage.
|Fiscal Impact:||May Have Fiscal Impact, But No Statement Yet Issued|
|Revenue Impact:||May Have Revenue Impact, But No Statement Yet Issued|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||In House Committee|
|Current Committee:||House Committee On Health Care|
|Potential Conflicts of Interest/Vote Explanations:||Potential Conflicts of Interest/Vote Explanation Documents|